"Final Big Market Cap Event Of Year": All Eyes On Novo's CagriSema GLP-1 Results
“Final Big Market Cap Event Of Year”: All Eyes On Novo’s CagriSema GLP-1 Results The next big market cap event for Novo Nordisk is the top-line efficacy results for its experimental obesity drug, CagriSema, with data from a late-stage trial expected by the end of the year. Novo previously stated that CagriSema could potentially lead to 25% weight […]
Discuss on Nostr!
Nostr Note ID note183dd2k06pv6kdsnvcps2e4v498lwsdtd9l7ajctescfg5wmga9eqdn7pef Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.